Amide derivatives

Details for Australian Patent Application No. 2004285749 (hide)

Owner AstraZeneca AB

Inventors Brown, Dearg Sutherland; Nash, Ian Alun

Agent Freehills

Pub. Number AU-B-2004285749

PCT Pub. Number WO2005/042502

Priority 0324790.5 24.10.03 GB

Filing date 22 October 2004

Wipo publication date 12 May 2005

Acceptance publication date 30 October 2008

International Classifications

C07D 239/91 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 487/08 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

11 May 2006 PCT application entered the National Phase

  PCT publication WO2005/042502 Priority application(s): WO2005/042502

30 October 2008 Application Accepted

  Published as AU-B-2004285749

26 February 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004285750-Process for the manufacture of the calcium salt of rosuvatatin (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[ methyl(methylsulfonyl) amino]pyrimidin-5-yl](3R, 5S)-3,5-dihydroxyhept-6-enoic acid and crystalline intermediates thereof

2004285747-Preparing active polymer extrudates